Inarigivir is a dinucleotide-based small molecule research compound with demonstrated antiviral activity against hepatitis B virus (HBV). It has been shown in research studies to significantly lower HBV DNA levels in the liver, supporting its investigation in both in vitro and in vivo models of chronic HBV infection.
Molekulargewicht:
587.5
CAS Nummer:
[475650-36-3]
Formel:
C20H26N7O10PS
Target-Kategorie:
HBV
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten